The fruits of Cudrania tricuspidata suppress development of atopic dermatitis in NC/Nga mice

Phytotherapy Research

Volumn 26, Issue 4, 2012, Pages 594-599

  Lee, Hoyoung ^a   Ha, Hyekyung ^a   Lee, Jun Kyung ^a   Seo, Chang Seob ^a   Lee, Nam Hun ^a   Jung, Da Young ^a   Park, Sang Joon ^b   Shin, Hyeun Kyoo ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

atopic dermatitis; Cudrania tricuspidata; Dermatophagoides farina; histamine; IgE; mTARC

Indexed keywords

CUDRANIA TRICUSPIDATA EXTRACT; DERMATOLOGICAL AGENT; HISTAMINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; PLANT EXTRACT; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CUDRANIA TRICUSPIDATA; DERMATOPHAGOIDES FARINAE; DRUG EFFICACY; DRUG MECHANISM; FRUIT; HERB; HISTAMINE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SKIN SWELLING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMOKINE CCL17; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; DRUG EVALUATION, PRECLINICAL; FRUIT; HISTAMINE; IMMUNOGLOBULIN E; MALE; MICE; MOLECULAR STRUCTURE; MORACEAE; PREDNISOLONE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

ANIMALIA; DERMATOPHAGOIDES; DERMATOPHAGOIDES FARINAE; MACLURA TRICUSPIDATA; MUS;

EID: 84859620504     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3577     Document Type: Article

References (23)

1. Aioi A, Tonogaio H, Suto H, et al,. 2001. Impairment of skin barrier function in NC/Nga mice as a possible model or atopic dermatitis. Br J Dermatol 144: 12-18.
2. An RB, Sohn DH, Kim YC,. 2006. Hepatoprotective compounds of the roots of Cudrania tricuspidata on tacrine-induce cytotoxicity in Hep G2 cells. Biol Pharm Bull 29: 838-840.
3. Chang SH, Jung EJ, Lim DG, et al,. 2008. Anti-inflammatory action of Cudrania tricuspidata on spleen cell and T lymphocyte proliferation. J Pharm Pharmacol 60: 1221-1226.
4. Darbonne WC,., Rice GC, Mohler MA, Apple T, Herbert CA, Valente AJ,. 1991. Red blood cells are a sink for inteleukin 8, a leukocute chemotaxin. J Clin Invest 88: 1362-1369.
5. Friedl R, Moeslinger T, Kopp B, Spieckermann PG,. 2001. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. Br J Pharmacol 134: 1663-1670.
6. Fujisawa T, Fulisawa R, Kato Y, Nakayama T, Morita A, Katsumata H,. 2002. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 110: 139-146.
7. Greaves MW, Wall PD,. 1996. Pathophysiology of itching. Lancet 348: 938-940.
8. Han XH, Hong SS, Hwang JS, et al,. 2005. Monoamine oxidase inhibitory constituents from the fruits of Cudrania tricuspidata. Arch Pharm Res 28: 1324-1327.
9. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M,. 2001. The eczema area and severity index (EASI) assessment of reliability in atopic dermatitis. Exp Dermatol 10: 11-18.
10. Hirotoshi F, Koichiro N, Xuyei Z, et al,. 2004. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis. J Dermatol Sci 35: 35-42.
11. Hoffman DR, Yamamoto FY, Geller B, Haddad Z,. 1975. Specific IgE antibodies in atopic eczema. J Allergy Clin Immunol 55: 256-267.
12. Janothan MS, Linda CS,. 1999. Atopic dermatitis. J Asthma Allergy Immunol 1: 1.
13. Kang DG, Hur TY, Lee GM, Oh H, Kwon TO, Lee HS,. 2002. Effects of Cudrania tricuspidata water extract on blood pressure and renal functions in NO-dependent hypertension. Life Sci 70: 2599-2609.
14. Kim HJ, Cha JY, Choi ML, Cho YS,. 2000. Antioxidative activities of water-soluble extracts of Morus alba and Cudrania tricuspidata. Agri Chem Biotechnol 43: 148-152.
15. Maekawa T, Yamaguchi O, Miuamato T, Nojima H, Kueaishi Y,. 2002. Effects of naltrexine on spontaneous itch-associated responses in NC/Nga mice with chronic dermatitis. Jpn J Pharmacol 90: 193-196.
16. Matsuda H, Watanabe N, Geba GP, et al,. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9: 461-466.
17. Park KH, Park YD, Han JM, et al,. 2006. Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata. Bioorg Med Chem Lett 16: 5580-5583.
18. Ramahnani S,. 1994. Lympokine production by human T cells in disease states. Annu Rev Immunol 12: 227-257.
19. Stander S, Steinhoff M,. 2002. Pathophysiology of pruritus in atopic dermatitis: and overview. Exp Dermatol 11: 12-24.
20. Sugawara N, Yamada H, Ote Y, Miura M, Terada N, Kurosawa M,. 2002. TARC in allergic disease. Allergy 57: 180-181.
21. Vercelli D, Jabara HH, Lauener RP, Geha RS,. 1990. IL-4 inhibits the syntheses of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immnol 144: 570-573.
22. Wahlgren CF,. 1992. Pathophysiology of itching in urticaria and atiopic dermatitis. Allergy 47: 65-75.
23. William A,. 2005. Atopic dermatitis. J Am Acad Dermatol 53: 86-93.